PayerTalkCE® Presents: Understanding Type 2 Inflammation: Spotlight on Moderate-to-Severe Asthma

This podcast provides health plan professionals with an in-depth discussion on the role of type 2 (T2) inflammation in asthma pathophysiology and the evolving treatment landscape. Experts explore the mechanisms driving T2 inflammation and how biomarkers can help guide therapy selection. The conversation highlights biologic treatments' clinical and economic considerations, including their impact on reducing exacerbations, optimizing outcomes, and managing healthcare costs. Panelists also discuss payer strategies for ensuring appropriate utilization, balancing financial stewardship with patient access, and the importance of collaboration between payers and providers to improve asthma care and reduce healthcare resource utilization. This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/type2-inflammation-asthma-management-ce/.